Hyperfine (HYPR) Debt Ratio (2020 - 2026)

Name: Hyperfine (HYPR) Debt Ratio (2020 - 2026) | Business Quant
Creator: Business Quant

Hyperfine posted quarterly Debt Ratio of 0.22 for Q1 2026, up 41393.29% on a QoQ basis from 0.0 in Q1 2023.

Hyperfine (HYPR) has 5 years of Debt Ratio data on file, last reported at 0.22 in Q1 2026.

For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.22; the trailing twelve-month figure through Mar 2026 stood at 0.22 (changed N/A YoY), and the FY2021 full-year result was 0.01, up 122.87% from the prior year.
Debt Ratio for Q1 2026 stood at 0.22, up from 0.0 in the prior quarter.
Across five years, Debt Ratio topped out at 0.22 in Q1 2026 and bottomed at 0.0 in Q3 2022.
The 3-year median for Debt Ratio is 0.0 (2023), against an average of 0.04.
Peak annual rise in Debt Ratio reached 3.37% in 2023, while the deepest fall reached 3.37% in 2023.
A 3-year view of Debt Ratio shows it stood at 0.0 in 2022, then climbed by 27.46% to 0.0 in 2023, then soared by 41393.29% to 0.22 in 2026.
The last three Debt Ratio figures came in at 0.22 (Q1 2026), 0.0 (Q1 2023), and 0.0 (Q3 2022), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	0.31
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	0.32
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	0.31
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.25
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	0.27
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	0.18
10	Hyperfine	149.47 Mn	108.20 Mn	1.98 Mn	0.22

Download Data 🔒